Bellows Capital Partners

Bellows Capital Partners is a specialized Life Sciences Corporate Development and Venture Strategy firm offering differentiated and dedicated support. We specialize in seeing successful commercial opportunities in technologies and helping scientists and entrepreneurs grow innovations out of the research lab. Our Philosophy Move Fast: deliver actionable outputs in less than 90 days Scoped Engagements: focus on defined outcomes, not open-ended consulting Strategy + Execution: deliver deal-ready materials, not just analysis Investor Viewpoint + Operator Mindset: align corporate development with financing and growth strategy Bellows Capital supports life sciences partners, particularly in computational (e.g, AI/ML) drug discovery technologies, that can provide an immediate and tangible efficiency to the drug discovery process, ranging from target discovery to development. Bellows produces support driven by fundamental analyses derived from scientific and commercial opportunities balanced with operational, regulatory, and financial risks. The Bellows Capital team’s combination of scientific, corporate, founder/operational, and financial experience allows the team to identify, execute, and realize opportunities in this specialized sector, with a specialized expertise.